# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-035155
Filing Date
2025-04-15
Accepted
2025-04-15 16:48:39
Documents
18
Period of Report
2025-06-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tm252518-1_pre14a.htm iXBRL | PRE 14A | 1153277
6 | GRAPHIC | px_25maxcyteproxy1pg01-bw.jpg | GRAPHIC | 379419
7 | GRAPHIC | px_25maxcyteproxy2pg01-4c.jpg | GRAPHIC | 178617
| Complete submission text file | 0001104659-25-035155.txt |  | 3036930

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | mxct-20241231.xsd | EX-101.SCH | 9636
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mxct-20241231_def.xml | EX-101.DEF | 2361
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mxct-20241231_lab.xml | EX-101.LAB | 34811
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mxct-20241231_pre.xml | EX-101.PRE | 3939
20 | EXTRACTED XBRL INSTANCE DOCUMENT | tm252518-1_pre14a_htm.xml | XML | 22541

Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40674 | Film No.: 25840187
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)